Rosalinda Termini

Statistics

Publications

Citations

171

H-Index

Active since

2021

Affiliations

Hospital Universitario 12 De Octubre(Current)

Instituto de Investigación Biomédica de Salamanca

Clinica Universidad de Navarra

Centro de Investigación Biomédica en Red de Cáncer

Hospital Clínico Universitario Lozano Blesa

Rosalinda Termini is an author at Hospital Universitario 12 De Octubre specializing in multiple myeloma, hematology, and flow cytometry immunophenotyping.

ORCID

Publications per year

2021–2023

Publications

Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma

Rosalinda Termini, David Žihala, Evangelos Terpos et al. · Clinical Cancer Research · 2022 · 52 citations · Full text

Medicine, Hematology, Oncology +17

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

Cirino Botta, Catarina Maia, Juan‐José Garcés et al. · Blood Advances · 2021 · 46 citations · Full text

Life Sciences, Hematology, Immunology +17

Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance

Cirino Botta, Cristina Pérez, Marta Larráyoz et al. · Nature Communications · 2023 · 33 citations · Full text

Life Sciences, Immunology, Oncology +17

Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance–Like Phenotype in Patients With Monoclonal Gammopathies

Leire Burgos, Luis‐Esteban Tamariz‐Amador, Noemí Puig et al. · Journal of Clinical Oncology · 2023 · 26 citations

Medicine, Hematology, Pathology +14

Circulating Tumor Cells (CTCs) in Smoldering and Active Multiple Myeloma (MM): Mechanism of Egression, Clinical Significance and Therapeutic Endpoints

Juan-José Garcés, Noemí Puig, Rosalinda Termini et al. · Blood · 2021 · 14 citations

Medicine, Hematology, Oncology +17

1–5 of 5